Company news
Central Pharmaceutical Jsc No. 3 (HNX:DP3) news
Central Pharmaceutical Jsc No. 3 news releases on 6ix. Latest, Apr 20, 2026: Central Pharmaceutical Joint Stock Company No3: Q1 2026 saw robust revenue…
Press releases & updates
Central Pharmaceutical Joint Stock Company No3: Q1 2026 saw robust revenue and profit growth, higher margins, and improved cash flow
April 20, 2026
Central Pharmaceutical Joint Stock Company No3: Net profit after tax surged 26.8% to VND 153.6 billion in 2025, with strong revenue growth
January 20, 2026
Central Pharmaceutical Joint Stock Company No3: Net profit and revenue rose year-over-year, but liquidity declined due to investments and dividends
October 20, 2025
Central Pharmaceutical Joint Stock Company No3: Q2/2025 net profit increased to VND 32.10 billion as margins and cash flow improved
July 18, 2025
Central Pharmaceutical Joint Stock Company No3: Net profit grew 8.3% year-over-year in Q1 2025, with improved cash flow and margins
May 19, 2025
Central Pharmaceutical Joint Stock Company No3: 2024 net revenue rose 1.9% and gross margin improved, but net profit slipped 3.3%
January 20, 2025
Central Pharmaceutical Joint Stock Company No3: Q3 2024 delivered higher profit and margin, but nine-month results reflect ongoing market headwinds
October 18, 2024
Central Pharmaceutical Joint Stock Company No3: H1 2024 saw lower profit and revenue, but improved cash and zero borrowings
July 19, 2024
22/09/2023, first trading day of additional listed shares
September 10, 2023
Official Admission of additional listing
August 28, 2023
04/06/2019, first trading day of additional listed shares
May 30, 2019
Stock ineligible for margin trading
August 25, 2017